Oppenheimer Comments on STRATA Skin Sciences, Inc.’s FY2022 Earnings (NASDAQ:SSKN)

STRATA Skin Sciences, Inc. (NASDAQ:SSKNGet Rating) – Equities researchers at Oppenheimer cut their FY2022 earnings estimates for STRATA Skin Sciences in a research note issued to investors on Thursday, May 12th. Oppenheimer analyst S. Kalia now expects that the medical device company will post earnings of ($0.19) per share for the year, down from their prior estimate of ($0.15). Oppenheimer also issued estimates for STRATA Skin Sciences’ Q1 2023 earnings at ($0.04) EPS and FY2023 earnings at ($0.11) EPS.

STRATA Skin Sciences (NASDAQ:SSKNGet Rating) last issued its earnings results on Wednesday, May 11th. The medical device company reported ($0.07) EPS for the quarter, missing analysts’ consensus estimates of ($0.06) by ($0.01). STRATA Skin Sciences had a negative return on equity of 18.49% and a negative net margin of 8.78%. During the same quarter in the previous year, the firm posted ($0.07) earnings per share.

Separately, Zacks Investment Research cut shares of STRATA Skin Sciences from a “hold” rating to a “sell” rating in a research report on Tuesday, May 3rd.

Shares of NASDAQ:SSKN opened at $1.09 on Monday. The stock has a market cap of $37.68 million, a PE ratio of -13.57 and a beta of 1.93. The company’s fifty day moving average is $1.38 and its 200 day moving average is $1.47. STRATA Skin Sciences has a 52 week low of $1.03 and a 52 week high of $1.95. The company has a quick ratio of 1.29, a current ratio of 1.56 and a debt-to-equity ratio of 0.29.

In other news, CEO Robert Joseph Moccia purchased 33,300 shares of the business’s stock in a transaction on Thursday, March 24th. The shares were acquired at an average price of $1.57 per share, with a total value of $52,281.00. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, CFO Christopher Lesovitz bought 23,131 shares of the business’s stock in a transaction dated Thursday, May 12th. The shares were bought at an average cost of $1.12 per share, for a total transaction of $25,906.72. Following the purchase, the chief financial officer now directly owns 23,131 shares in the company, valued at approximately $25,906.72. The disclosure for this purchase can be found here. In the last three months, insiders acquired 71,214 shares of company stock worth $101,545. Insiders own 42.90% of the company’s stock.

A number of hedge funds and other institutional investors have recently modified their holdings of the stock. Western Standard LLC purchased a new position in STRATA Skin Sciences in the third quarter worth about $875,000. Cannell Capital LLC raised its holdings in shares of STRATA Skin Sciences by 1.6% during the third quarter. Cannell Capital LLC now owns 874,321 shares of the medical device company’s stock valued at $1,609,000 after purchasing an additional 13,496 shares during the last quarter. We Are One Seven LLC purchased a new position in shares of STRATA Skin Sciences during the fourth quarter valued at approximately $105,000. Essex Investment Management Co. LLC purchased a new position in shares of STRATA Skin Sciences during the fourth quarter valued at approximately $382,000. Finally, Susquehanna International Group LLP raised its holdings in shares of STRATA Skin Sciences by 90.6% during the fourth quarter. Susquehanna International Group LLP now owns 57,583 shares of the medical device company’s stock valued at $85,000 after purchasing an additional 27,376 shares during the last quarter. 37.50% of the stock is owned by institutional investors.

STRATA Skin Sciences Company Profile (Get Rating)

STRATA Skin Sciences, Inc, a medical technology company, develops, commercializes, and markets products for the treatment of dermatologic conditions in the United States, Europe, the Middle East, Asia, Australia, South Africa, and Central and South America. The company operates in two segments, Dermatology Recurring Procedures and Dermatology Procedures Equipment.

Featured Articles

Earnings History and Estimates for STRATA Skin Sciences (NASDAQ:SSKN)

Receive News & Ratings for STRATA Skin Sciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for STRATA Skin Sciences and related companies with MarketBeat.com's FREE daily email newsletter.